| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8525975 | Biomedicine & Pharmacotherapy | 2018 | 7 Pages |
Abstract
Collectively, the data suggest that AENJ inhibits expression of COX and iNOS by blocking NF-κB signaling pathways and suppresses the activity of macrophages by downregulating Ninj1 and MMPs. Therefore, AENJ may be a useful preventive neutraceutical, or therapeutic agent against inflammatory disorders.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Su Jung Hwang, Eun-Young Ahn, Youmie Park, Hyo-Jong Lee,